Randomized Controlled Trial of LAIV vs TIV Vaccines in Schools
NCT01995851 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 902
Last updated 2015-05-27
Summary
Overall, this study will determine (1) the effect of vaccine type (FluMist vs. TIV) on immunization rates, (2) assess the feasibility of school immunization clinics, and (3) inform a larger study to understand the effects of these two vaccines on reducing influenza.
Conditions
Sponsors & Collaborators
-
Canadian Institutes of Health Research (CIHR)
collaborator OTHER_GOV -
Ontario Agency for Health Protection and Promotion
collaborator OTHER_GOV -
Peterborough County-City Health Unit
collaborator UNKNOWN -
Dalhousie University
lead OTHER
Principal Investigators
-
Scott A Halperin, MD, PhD · Nominated Principal Investigator, PHAC/CIHR Influenza Research Network (Dalhousie University)
Eligibility
- Min Age
- 3 Years
- Max Age
- 14 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-10-31
- Primary Completion
- 2014-01-31
- Completion
- 2014-04-30
Countries
- Canada
Study Locations
More Related Trials
-
A Phase I Safety and Immunogenicity Study of Mix and Match of Licensed Flu Vaccine and Flumist
NCT00231907 ·Status: COMPLETED ·Phase: PHASE1
-
Immunologic Response to FluMist vs. Flucelvax
NCT03982069 ·Status: COMPLETED ·Phase: PHASE4
-
A Trial on the Efficacy, Safety and Immunogenicity of Live-Attenuated Influenza Vaccine (LAIV)
NCT02964065 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate Impact of School-based Influenza Vaccination on School Populations
NCT00844051 ·Status: COMPLETED ·Phase: NA
-
Live Attenuated Influenza Vaccine (LAIV) Versus Trivalent Inactivated Influenza Vaccine in Healthy Adults 18-49 Years
NCT03101462 ·Status: COMPLETED ·Phase: PHASE4
-
Study of a Flu Vaccine in Children
NCT00001127 ·Status: COMPLETED ·Phase: PHASE3
-
Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (FluMist) and Measles, Mumps, Rubella, and Varicella Vaccines Administered Concurrently to Healthy Children
NCT00192491 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of Attenuated Versus Inactivated Flu Vaccine in Twin Sets
NCT03898986 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old
NCT01992107 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Seasonal Influenza Vaccine for 2010-2011 in Young Children
NCT01180621 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety of Two Influenza Vaccines in Children and Adolescents 3 to <18 Years of Age at Risk for Influenza-Related Complications
NCT01998477 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of a School-based Influenza Vaccination Program
NCT00961337 ·Status: COMPLETED ·Phase: PHASE4
-
Safety of Two Trivalent Influenza Vaccines Evaluated in Children and Adolescents 4 to 17 Years of Age
NCT01857206 ·Status: COMPLETED ·Phase: PHASE3
-
Sanofi Pasteur, TIV + H1N1, Pediatric Population
NCT00943202 ·Status: COMPLETED ·Phase: PHASE2
-
Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold- Adapted (CAIV-T) in Healthy Children Attending Day Care Centers
NCT00192283 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Age and Prior Immunity to Response to Seasonal Influenza Vaccines in Children
NCT01246999 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Inactivated and Live, Attenuated Influenza Vaccine in Children 5-9 Years of Age-Year 3 Amendment
NCT00138385 ·Status: COMPLETED ·Phase: PHASE4
-
Self-Administered Nasal Influenza Feasibility Study
NCT01933048 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Immunogenicity of Trivalent Subunit Inactivated Flu Vaccine Administered to Healthy Children and Adolescents 3 to 17 Years of Age
NCT01209780 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase II, Trial to Assess the Safety and Tolerability of Influenza Virus Vaccine, CAIV-T in Healthy Children and Adolescents Ages 6 to Less Than 18 Years.
NCT00192179 ·Status: COMPLETED ·Phase: PHASE2
-
Cluster RCT - Evaluating Effectiveness of a Guide and Tools for Influenza Immunization Campaign Planners
NCT01207518 ·Status: UNKNOWN ·Phase: NA
-
Control of Epidemic Influenza Through a School-based Influenza Vaccination Program
NCT00138294 ·Status: COMPLETED ·Phase: PHASE4
-
Trial of the Safety, Transmissibility, and Phenotypic and Genotypic Stability of Influenza Virus Vaccine,(CAIV-T), in Children Who Attend Day Care. (Final Report Version 2.0)
NCT00192361 ·Status: COMPLETED ·Phase: PHASE3
-
Childhood Influenza Immunisation Invitation Trial in Schools
NCT02883972 ·Status: WITHDRAWN ·Phase: NA
-
Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live, Cold-Adapted (CAIV-T) in Healthy Children
NCT00192244 ·Status: COMPLETED ·Phase: PHASE3